Exploration of CTCF post-translation modifications uncovers Serine-224 phosphorylation by PLK1 at pericentric regions during the G2/M transition

  1. Brian C del Rosario
  2. Andrea J Kriz
  3. Amanda M del Rosario
  4. Anthony Anselmo
  5. Christopher J Fry
  6. Forest M White
  7. Ruslan I Sadreyev
  8. Jeannie T Lee  Is a corresponding author
  1. Massachusetts General Hospital, United States
  2. Koch Institute for Integrative Cancer Research at MIT, United States
  3. Cell Signaling Technologies, United States

Abstract

The zinc finger CCCTC-binding protein (CTCF) carries out many functions in the cell. Although previous studies sought to explain CTCF multivalency based on sequence composition of binding sites, few examined how CTCF post-translational modification (PTM) could contribute to function. Here, we performed CTCF mass spectrometry, identified a novel phosphorylation site at Serine 224 (Ser224-P), and demonstrate that phosphorylation is carried out by Polo kinase 1 (PLK1). CTCF Ser224-P is chromatin-associated, mapping to at least a subset of known CTCF sites. CTCF Ser224-P accumulates during the G2/M transition of the cell cycle and is enriched at pericentric regions. The phospho-obviation mutant, S224A, appeared normal. However, the phospho-mimic mutant, S224E, is detrimental to mouse embryonic stem cell colonies. While ploidy and chromatin architecture appear unaffected, S224E mutants differentially express of hundreds of genes, including p53 and p21. We have thus identified a new CTCF PTM and provided evidence of biological function.

Data availability

High-throughput sequencing data are available in the National Center for Biotechnology Information GEO repository under accession GSE119697

The following data sets were generated

Article and author information

Author details

  1. Brian C del Rosario

    Department of Molecular Biology, Massachusetts General Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  2. Andrea J Kriz

    Department of Molecular Biology, Massachusetts General Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  3. Amanda M del Rosario

    Koch Institute for Integrative Cancer Research at MIT, Cambridge, United States
    Competing interests
    No competing interests declared.
  4. Anthony Anselmo

    Department of Molecular Biology, Massachusetts General Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  5. Christopher J Fry

    Cell Signaling Technologies, Danvers, United States
    Competing interests
    No competing interests declared.
  6. Forest M White

    Koch Institute for Integrative Cancer Research at MIT, Cambridge, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1545-1651
  7. Ruslan I Sadreyev

    Department of Molecular Biology, Massachusetts General Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  8. Jeannie T Lee

    Department of Molecular Biology, Massachusetts General Hospital, Boston, United States
    For correspondence
    lee@molbio.mgh.harvard.edu
    Competing interests
    Jeannie T Lee, Reviewing editor, eLifecofounder and member of the Scientific Advisory Boards of Translate Bio and Fulcrum Therapeutics.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7786-8850

Funding

Howard Hughes Medical Institute

  • Jeannie T Lee

National Institutes of Health (R37-GM58839)

  • Jeannie T Lee

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2019, del Rosario et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,686
    views
  • 375
    downloads
  • 19
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Brian C del Rosario
  2. Andrea J Kriz
  3. Amanda M del Rosario
  4. Anthony Anselmo
  5. Christopher J Fry
  6. Forest M White
  7. Ruslan I Sadreyev
  8. Jeannie T Lee
(2019)
Exploration of CTCF post-translation modifications uncovers Serine-224 phosphorylation by PLK1 at pericentric regions during the G2/M transition
eLife 8:e42341.
https://doi.org/10.7554/eLife.42341

Share this article

https://doi.org/10.7554/eLife.42341

Further reading

    1. Chromosomes and Gene Expression
    Carlos Moreno-Yruela, Beat Fierz
    Insight

    Specialized magnetic beads that bind target proteins to a cryogenic electron microscopy grid make it possible to study the structure of protein complexes from dilute samples.

    1. Chromosomes and Gene Expression
    2. Structural Biology and Molecular Biophysics
    Liza Dahal, Thomas GW Graham ... Xavier Darzacq
    Research Article

    Type II nuclear receptors (T2NRs) require heterodimerization with a common partner, the retinoid X receptor (RXR), to bind cognate DNA recognition sites in chromatin. Based on previous biochemical and overexpression studies, binding of T2NRs to chromatin is proposed to be regulated by competition for a limiting pool of the core RXR subunit. However, this mechanism has not yet been tested for endogenous proteins in live cells. Using single-molecule tracking (SMT) and proximity-assisted photoactivation (PAPA), we monitored interactions between endogenously tagged RXR and retinoic acid receptor (RAR) in live cells. Unexpectedly, we find that higher expression of RAR, but not RXR, increases heterodimerization and chromatin binding in U2OS cells. This surprising finding indicates the limiting factor is not RXR but likely its cadre of obligate dimer binding partners. SMT and PAPA thus provide a direct way to probe which components are functionally limiting within a complex TF interaction network providing new insights into mechanisms of gene regulation in vivo with implications for drug development targeting nuclear receptors.